Home/Filings/4/0001209191-20-006290
4//SEC Filing

Reiter Sarah 4

Accession 0001209191-20-006290

CIK 0001469443other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:13 PM ET

Size

7.1 KB

Accession

0001209191-20-006290

Insider Transaction Report

Form 4
Period: 2020-02-03
Reiter Sarah
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-02-03+50,000121,705 total
    Exercise: $4.91Exp: 2030-02-03Common Stock (50,000 underlying)
  • Purchase

    Common Stock

    2020-02-03$1.72/sh+700$1,2043,800 total
Footnotes (2)
  • [F1]Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.
  • [F2]The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024.

Issuer

Arcadia Biosciences, Inc.

CIK 0001469443

Entity typeother

Related Parties

1
  • filerCIK 0001734605

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:13 PM ET
Size
7.1 KB